Stocktoria

POSITRON CORP POSC

OTC · OOTC · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 1994-02-10

POSITRON CORP financials (annual, from 10-K)

Revenue
2010201120122013201420242025
Net income
2010201120122013201420242025
Free cash flow
2010201120122013201420242025

Bars are annual figures from 2010 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2014FY2013FY2012FY2011FY2010
Revenue$461,452$587,500$1.5M$1.6M$2.8M$6.7M$4.6M
Gross profit-$2.1M-$341,984$104,000$424,000$829,000$277,000$59,000
R&D expense$471,000$564,000$940,000$1.3M$1.3M
Operating income-$10.5M-$2.2M-$2.7M-$3.3M-$4.7M-$4.4M-$14.4M
Interest expense$125,338$142,402$1.8M$2.1M$1.8M$1.2M$43,000
Income tax$0$0$0
Net income-$10.6M-$2.4M-$2.6M-$7.1M-$8.0M-$6.1M-$10.9M
EPS (diluted)$-0.34$-0.09
Operating cash flow-$4.7M-$1.7M-$2.4M-$3.0M-$2.2M-$4.1M-$4.7M
Free cash flow-$2.4M-$3.1M-$2.3M-$4.1M-$4.9M
Cash & equivalents$208,000$1.7M$243,000$1,000$1.1M
Inventory$680,000$1.3M$330,000$547,000$551,000$741,000$622,000
Total assets$4.0M$1.8M$1.9M$3.9M$2.7M$2.3M$5.2M
Total liabilities$2.6M$2.5M$2.7M$15.1M$8.9M$5.2M$5.3M
Shareholders' equity$1.4M-$656,725-$837,000-$11.2M-$6.2M-$2.9M-$86,000

Growth · year-over-year · Revenue CAGR -31.9%

MetricFY2025FY2024FY2014FY2013FY2012FY2011FY2010
Revenue growth-21.5%-59.9%-10.1%-41.8%-58.0%+44.1%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Source: SEC EDGAR filings · CIK 0000844985 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.